Basic Information
| LncRNA/CircRNA Name | SNHG6 |
| Synonyms | NA |
| Region | GRCh38_8:66921684-66926398 |
| Ensemble | ENSG00000245910 |
| Refseq | NR_002599 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | cholangiocarcinoma |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot, Luciferase reporter assay etc |
| Sample | CCA and normal tissues, CCA cell lines (HCCC-9810 and RBE) |
| Expression Pattern | up-regulated |
| Function Description | SNHG6 was upregulated in CCA tissues and associated with poor overall survival in CCA patients.SNHG6 promoted CCA cells proliferation, migration and HUVECs tube formation. |
| Pubmed ID | 32226515 |
| Year | 2020 |
| Title | Long Noncoding RNA SNHG6 Promotes Proliferation and Angiogenesis of Cholangiocarcinoma Cells Through Sponging miR-101-3p and Activation of E2F8 |
External Links
| Links for SNHG6 | GenBank HGNC NONCODE |
| Links for cholangiocarcinoma | OMIM COSMIC |